Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study).

Autor: Sockel K; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Neu A; Altona Children's Hospital, Hamburg, Germany., Goeckenjan M; Department for Gynaecology and Obstetrics, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Ditschkowski M; Department of Hematology and Stem Cell Transplantation, University of Duisburg-Essen, University Hospital Essen, Essen, Germany., Hilgendorf I; Universitätsklinikum Jena, Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Jena, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ayuk FA; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Stoelzel F; Division of Stem Cell Transplantation and Cellular Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Middeke JM; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Eder M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Bethge W; Department of Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Finke J; Department of Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bertz H; Department of Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Kaufmann M; 2nd Department of Internal Medicine, Oncology, and Hematology, Robert Bosch Hospital, Stuttgart, Germany., Platzbecker U; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany., Beverungen D; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany., Schmid C; Augsburg University Hospital and Medical Faculty and Bavarian Cancer Research Center, Augsburg, Germany., von Bonin M; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Egger-Heidrich K; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Heberling L; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Trautmann-Grill K; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Teipel R; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Bug G; Department of Medicine, Hematology, and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Tischer J; Department of Medicine III, Ludwig Maximilian University, University Hospital of Munich, Munich, Germany., Fraccaroli A; Department of Medicine III, Ludwig Maximilian University, University Hospital of Munich, Munich, Germany., Fante M; Department of Internal Medicine III, Hematology, and Oncology, University Hospital Regensburg, Regensburg, Germany., Wolff D; Department of Internal Medicine III, Hematology, and Oncology, University Hospital Regensburg, Regensburg, Germany., Luft T; Department of Internal Medicine V (Hematology/Oncology/Rheumatology), Heidelberg University Hospital, Heidelberg, Germany., Winkler J; Department of Internal Medicine 5, University Hospital Erlangen, Erlangen, Germany., Schäfer-Eckart K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany., Scheid C; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Holtick U; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Klein S; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Blau IW; Department of BMT, Clinic of Hematology, Oncology, and Tumor Immunology, Charite-University Medicine Berlin, Berlin, Germany., Burchert A; Department of Hematology, Oncology, and Immunology, Carreras Leukemia Center, Philips University Marburg and University Hospital Gießen and Marburg, Marburg, Germany., Wulf G; Hematology and Medical Oncology, University Medicine Göttingen, Göttingen, Germany., Hasenkamp J; Hematology and Medical Oncology, University Medicine Göttingen, Göttingen, Germany., Schwerdtfeger R; Center for Hematopoietic Cell Transplantation, Deutsche Klinik für Diagnostik Helios Klinik, Wiesbaden, Germany., Kaun S; Hematology, Oncology und Infectiology, Clinic Bremen-Mitte, Bremen, Germany., Junghanss C; Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany., Wortmann F; Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Lübeck, Germany., Winter S; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Neidlinger H; German Registry of Stem Cell Transplantation (DRST), Ulm, Germany., Theuser C; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany., Beyersmann J; Institute of Statistics, University Ulm, Ulm, Germany., Bornhaeuser M; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; National Center for Tumor Diseases, Partner Site Dresden, Dresden, Germany., Schmeller S; Institute of Statistics, University Ulm, Ulm, Germany., Schetelig J; Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany.

Publikováno v: Blood [Blood] 2024 Oct 03; Vol. 144 (14), pp. 1532-1542.

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients

Autor: Röllig, C. ^*, Kramer, M., Gabrecht, M., Hänel, M., Herbst, R., Kaiser, U., Schmitz, N., Kullmer, J., Fetscher, S., Link, H., Mantovani-Löffler, L., Krümpelmann, U., Neuhaus, T., Heits, F., Einsele, H., Ritter, B., Bornhäuser, M., Schetelig, J., Thiede, C., Mohr, B., Schaich, M., Platzbecker, U., Schäfer-Eckart, K., Krämer, A., Berdel, W.E., Serve, H., Ehninger, G., Schuler, U.S.

Publikováno v: In Annals of Oncology April 2018 29(4):973-978

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative forFLT3-ITD,NPM1- or biallelicCEBPA mutations

Autor: Heidrich, K. ^*, Thiede, C., Schäfer-Eckart, K., Schmitz, N., Aulitzky, W.E., Krämer, A., Rösler, W., Hänel, M., Einsele, H., Baldus, C.D., Trappe, R.U., Stölzel, F., Middeke, J.M., Röllig, C., Taube, F., Kramer, M., Serve, H., Berdel, W.E., Ehninger, G., Bornhäuser, M., Schetelig, J.

Publikováno v: In Annals of Oncology November 2017 28(11):2793-2798

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.